Parenteral Nutrition Clinical Trial
Official title:
Analysis of the Pharmaceutical Validation of Picc Line Installation Requests at the Nîmes University Hospital
The picc line is a central venous catheter inserted peripherally into a deep vein in the arm (cephalic, basilic or axillary) whose distal end is located at the junction of the superior vena cava / atrium. It is installed for a minimum of 7 days (1), and can be stored for up to 6 months or more if it is functional. For treatments with an indication of more than 3 months, it is common practice to place an implantable catheter chamber. The main indications for picc line placement are: long-term antibiotic therapy, parenteral nutrition, chemotherapy or long-term venous approach when difficulties are encountered in applying a peripheral venous route to the patient. Quickly adopted by medical teams, picc lines are not without risk, however, and three complications are mainly reported: catheter obstruction, deep vein thrombosis and infections. In order to avoid any risk of unnecessary complications, it therefore seems appropriate to target the most appropriate device upstream of the procedure according to the provisional indication. An inventory of pharmaceutical interventions carried out during picc line requests would make it possible to lay the foundations for considering actions to be implemented with the various services requesting picc line and proposals for improvement for the follow-up of patients with picc line to reduce the risk of complications.
n/a
| Status | Clinical Trial | Phase | |
|---|---|---|---|
| Recruiting |
NCT03606863 -
Peripheral Parenteral Nutrition vs Conventional Fluid in Colorectal Resection in ERAS
|
Phase 3 | |
| Completed |
NCT00451646 -
Study Comparing the Safety and Tolerance of SMOFlipid 20% in Long-term Treatment With Parenteral Nutrition
|
Phase 3 | |
| Enrolling by invitation |
NCT06161350 -
The Multi-disciplinary Approach of Children With Feeding Difficulties and Tube Feeding in UZB Between 2000 and 2021
|
||
| Completed |
NCT04234152 -
Complete Shielding of Multivitamins to Reduce Toxic Peroxides in the Parenteral Nutrition: A Pilot Study
|
N/A | |
| Completed |
NCT00672854 -
Study Comparing a Soybean Oil-Based With an Olive Oil-Based Lipid Emulsion in ICU Patients Requiring TPN
|
Phase 2/Phase 3 | |
| Active, not recruiting |
NCT01839617 -
Study Comparing Early and Late Nutrition in Cancer Patients Undergoing Abdominal Surgery
|
N/A | |
| Completed |
NCT05299099 -
Clinical Trial to Evaluate the Safety and Efficacy of IN-C006 Inj. Compared With RCN301
|
Phase 3 | |
| Withdrawn |
NCT02463812 -
Lipid Infusion Following Major Surgery
|
N/A | |
| Completed |
NCT04816734 -
Initial Parenteral Nutrition Education of Parent Assessment Plan
|
N/A | |
| Terminated |
NCT01814956 -
Different Lipid Emulsions in Acute Lung Injury Patients
|
Phase 4 | |
| Completed |
NCT04234490 -
Longitudinal Evaluation of the Impact of Parenteral Nutrition
|
||
| Recruiting |
NCT05519761 -
A Retrospective, Observational, Multicenter Study to Evaluate the Safety and Performance of POLYSITE® and SEESITE® Implantable Ports
|
||
| Completed |
NCT00321165 -
The AOT (Acridine Orange and Taurolidine) Trial
|
Phase 3 | |
| Completed |
NCT00292279 -
The Impact of Omega-3 Fat Emulsion on Clinical Outcome of Post-Operative Cancer Patients
|
Phase 3 | |
| Recruiting |
NCT03157245 -
Incidence of Deep Vein Thrombosis on Central Venous Catheters in the Post Operative Period of Carcinologic Surgery
|
N/A | |
| Recruiting |
NCT03693287 -
Personalized vs Standardized PN for Preterm Infants >1250g
|
Phase 4 | |
| Completed |
NCT02828150 -
Integrative Parenteral Nutrition in Cancer Patients
|
N/A | |
| Completed |
NCT00798681 -
Evaluating the Influence of Ready-to-use (RTU) Parenteral Nutrition in the Clinical Outcome of Patients Study
|
Phase 4 | |
| Completed |
NCT00512629 -
Cholestasis Prevention: Efficacy of IV Fish Oil
|
Phase 1 | |
| Completed |
NCT03792100 -
Efficacy & Safety of SmofKabiven Emulsion for Infusion vs Hospital Compounded "All in One" for Parenteral Nutrition
|
Phase 3 |